Karl T - Search Results

1

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.

Karl T, Garner B, Cheng D. Karl T, et al. Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247. Behav Pharmacol. 2017. PMID: 27471947 Review.

2

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.

Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T. Long LE, et al. Among authors: karl t. Int J Neuropsychopharmacol. 2010 Aug;13(7):861-76. doi: 10.1017/S1461145709990605. Epub 2009 Sep 29. Int J Neuropsychopharmacol. 2010. PMID: 19785914 Free article.

3

Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?

Karl T, Burne TH, Van den Buuse M, Chesworth R. Karl T, et al. Behav Brain Res. 2011 Oct 1;223(2):336-41. doi: 10.1016/j.bbr.2011.04.051. Epub 2011 May 13. Behav Brain Res. 2011. PMID: 21605597

4

Cognition in female transmembrane domain neuregulin 1 mutant mice.

Chesworth R, Downey L, Logge W, Killcross S, Karl T. Chesworth R, et al. Among authors: karl t. Behav Brain Res. 2012 Jan 1;226(1):218-23. doi: 10.1016/j.bbr.2011.09.019. Epub 2011 Sep 16. Behav Brain Res. 2012. PMID: 21944941

5

Cognitive phenotyping of amyloid precursor protein transgenic J20 mice.

Karl T, Bhatia S, Cheng D, Kim WS, Garner B. Karl T, et al. Behav Brain Res. 2012 Mar 17;228(2):392-7. doi: 10.1016/j.bbr.2011.12.021. Epub 2011 Dec 19. Behav Brain Res. 2012. PMID: 22197298

6

The therapeutic potential of the endocannabinoid system for Alzheimer's disease.

Karl T, Cheng D, Garner B, Arnold JC. Karl T, et al. Expert Opin Ther Targets. 2012 Apr;16(4):407-20. doi: 10.1517/14728222.2012.671812. Epub 2012 Mar 27. Expert Opin Ther Targets. 2012. PMID: 22448595 Review.

7

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.

Long LE, Chesworth R, Huang XF, Wong A, Spiro A, McGregor IS, Arnold JC, Karl T. Long LE, et al. Among authors: karl t. PLoS One. 2012;7(4):e34129. doi: 10.1371/journal.pone.0034129. Epub 2012 Apr 3. PLoS One. 2012. PMID: 22509273 Free PMC article.

8

The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.

Arnold JC, Boucher AA, Karl T. Arnold JC, et al. Among authors: karl t. Curr Pharm Des. 2012;18(32):5113-30. doi: 10.2174/138161212802884726. Curr Pharm Des. 2012. PMID: 22716133

9

Novel behavioural characteristics of the APP(Swe)/PS1ΔE9 transgenic mouse model of Alzheimer's disease.

Cheng D, Logge W, Low JK, Garner B, Karl T. Cheng D, et al. Among authors: karl t. Behav Brain Res. 2013 May 15;245:120-7. doi: 10.1016/j.bbr.2013.02.008. Epub 2013 Feb 16. Behav Brain Res. 2013. PMID: 23419740

10

Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.

Kim WS, Li H, Ruberu K, Chan S, Elliott DA, Low JK, Cheng D, Karl T, Garner B. Kim WS, et al. Among authors: karl t. J Neurosci. 2013 Mar 6;33(10):4387-94. doi: 10.1523/JNEUROSCI.4165-12.2013. J Neurosci. 2013. PMID: 23467355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results